CHRONIC HEART FAILURE AS A MANIFESTATION OF CARDIOTOXICITY IN CANCER PATIENTS
Abstract
The use of modern methods of chemoradiotherapy has led to a significant increase in the life expectancy of cancer patients. At the same time, oncologists and physicians of therapeutic specialties are increasingly faced with problems of complications from ongoing antitumor treatment. One of the most common side effects is cardiotoxity, which significantly affect the prognosis in the short and long term. The most severe and prognostically unfavorable complications include myocardial dysfunction and chronic heart failure. The problem also lies in the fact that this complication can be asymptomatic for a long time and when cardiac complaints appear, such patients do not consider it necessary to report the antitumor treatment carried out in the past to a cardiologist.